# DBV Technologies S.A. (DBVT)

- Sector: Healthcare · Industry: Biotechnology
- SEC CIK: 0001613780 ([filings on EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001613780))
- Full page: https://inspectstocks.com/stocks/dbvt
- Data as of: price 2026-09-25; newest filing used 2026-07-16; latest fiscal period ended 2026-06-30

## Grade

**F-** on the growth-and-cash rubric, 0 of 5 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Revenue growing overall | failed | $5M | $5.3M |
| Revenue growing recently | failed | $5M | $5.6M |
| Free cash flow positive | failed | -$170.6M |  |
| Free cash flow growing overall | failed | -$170.6M | -$91M |
| Free cash flow growing recently | failed | -$170.6M | -$121.7M |

Business quality (the + / − mark): 1 of 6 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | failed | -3,506.5% |  |
| Healthy profit margin | failed | -3,506.5% |  |
| Strong operating margin | failed | -3,543.1% |  |
| Good return on equity | failed | -104.3% |  |
| Debt under control | passed | 0.04 |  |
| Turns sales into cash | failed | -3,399.3% |  |

How the grade works: the letter counts failed checks (none → A, one → B, two → C, three → D, four or more → F). It is built from SEC filings only — the share price never enters it — and describes the business, not whether the stock is worth buying.

## Key figures

In US dollars, as filed.

| Measure | Value |
| --- | --- |
| Revenue, trailing twelve months | $5M |
| Net income, trailing twelve months | -$176M |
| Free cash flow, trailing twelve months | -$170.6M |
| Net margin | -3,506.5% |
| Operating margin | -3,543.1% |
| Return on equity | -104.3% |
| Debt to equity | 0.04 |
| Diluted EPS, trailing twelve months | -$0.70 |
| Share price | $11.56 |
| Market value | $3.4B |
| Price / sales | 681.9x |

## More on this company

- [Overview](https://inspectstocks.com/stocks/dbvt)
- [Financial statements](https://inspectstocks.com/stocks/dbvt/financials)
- [Competitors](https://inspectstocks.com/stocks/dbvt/peers)
- [Earnings](https://inspectstocks.com/stocks/dbvt/earnings)

---

Source: InspectStocks, built from the company’s own SEC filings. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.